1[1]Sarnak MJ,Levey AS,Schoolwerth AC,et al.Kidney disease as a risk factor for development of cardiovascular disease:a statement from the American Heart ASsociation Councils on Kidney in Cardiovascular Disease,High Blood Research,Clinical Cardiology,and Epidemiology and Prevention.Circulation,2003,108:2154-2169.
2[2]McAlister FA,Ezekowitz J,Tomelli M,et al.Renal Insufficiency and Heart Failure:Prognostic and Therapeutic Implications From a Prospective Cohort Study.Circulation,2004,109:1004-1009.
3[3]Mann JJ,Gerstein HC,Pogue J,et al.Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril:the HOPE randomized trial.Ann Intern Med,2001,134:629-636.
4[4]National Institues of Health,National Institute of Diabetes and Digestive and Kidney Disease.USRDS 1997 Annual Data Report.Bethesda,MD,USA:National Institutes of Health.National Institutes of Diabetes and Digestive and Kidney Disease,1997.
5[5]CIBIS Investigator and Committees.A randomized trial of betablockade in heart failure:the Cardiac Insufficiency Bisoprolol Study(CIBIS).Circulation,1994,90:1765-1773.
6[6]Colueci WS,Packer M,Bristow MR,et al.For the US Carvedilol Heart Failure Study Group.Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure.Circulation,1996,94:2800-2806.
7[7]Hou FF,Zhang X,Zhang GH,et al.Efficancy and safety of Benazepril for advanced Chronic Renal Insufficiency.N Engl J Med,2006,354:131-140.
8[8]Risler T,Schwab A,Kramer B,et al.Comparative pharmacokinetics and pharmacodynamics of loop diuretics in renal failure.Cardiology,1994,84:155-161.
9[9]Alpert MA.Cardiovascular factors influencing survival in dialysis patients.Adv Perit Dial,1996,12:110-119.
10[10]Packer M,Lee WH,Medina N,et al.Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure.Ann Intern Med,1987,106:346-354.
7Shlipak MG, Massie BM. The clinical challenge of cardiorenal syndrome[J]. Circulation , 2004, 110: 1514.
8Hillege HL, Girbes AR, de Kam PJ, et al . Renal function, neurohormonal activation, and survival in patients with chronic heart failure[J]. Circulation , 2000, 102: 203-210.
9De Filippi CR , Seliger SL , Maynard S, et al . Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality[J]. Clin Chem ,2007,53 (8):1511-1519.
10Silverberg DS, Wexler D, Iaina A. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron[J]. Nephrol , 2004, 17: 749-761.
